+++UPDATE (20.03.2022): this collaboration opportunity is already closed+++
Dear Colleagues,
We have an exciting dataset with potential to be published in the Journal of Medical Internet Research (JMIR, IF=5, Q1-ranking), and we are searching for an experienced writer who can prepare the first draft of the manuscript and take the role of first author. In more detail:
WE ARE OFFERING:
# Ready-to-be used dataset
# Ready-to-be used manuscript concept and writing-guidance
# First-author position for the colleague who can help us to prepare the manuscript draft
# All journal-related publication fees will be covered by us
WE ARE SEARCHING FOR:
# Expertise in scientific writing, demonstrated by relevant previous publications as first author
# Willingness to write the first draft of the manuscript
# Of particular benefit would be experience in one or several of the following scientific areas: public health, open innovation, crowdsourcing, Twitter, Social Media, COVID-19
In case of interest, please contact Dr. Emil Parvanov at: e_parvanov@mail.bg – providing information particularly about your previous publications record.
For a reference, here are several relevant previous publications from our team:
Yeung AWK, Tosevska A, Klager E, Eibensteiner F, Tsagkaris C, Parvanov ED, Nawaz FA, Völkl-Kernstock S, Schaden E, Kletecka-Pulker M, Willschke H, Atanasov AG. Medical and Health-Related Misinformation on Social Media: Bibliometric Study of the Scientific Literature. J Med Internet Res. 2022 Jan 25;24(1):e28152. doi: 10.2196/28152. PMID: 34951864; PMCID: PMC8793917.
Yeung AWK, Wochele-Thoma T, Eibensteiner F, Klager E, Hribersek M, Parvanov ED, Hrg D, Völkl-Kernstock S, Kletecka-Pulker M, Schaden E, Willschke H, Atanasov AG. Analysis of official websites providing online information on COVID-19 vaccination: readability, content quality, and listing of side effects. JMIR Public Health Surveill. 2022 Jan 20. doi: 10.2196/34003. Epub ahead of print. PMID: 35073276.
Yeung AWK, Kletecka-Pulker M, Eibensteiner F, Plunger P, Völkl-Kernstock S, Willschke H, Atanasov AG. Implications of Twitter in Health-Related Research: A Landscape Analysis of the Scientific Literature. Front Public Health. 2021 Jul 9;9:654481. doi: 10.3389/fpubh.2021.654481. PMID: 34307273; PMCID: PMC8299201.
Willschke H, Wochele-Thoma T, Atanasov AG, Klager E, Haslinger C, Kletecka-Pulker M, Laxar D, Ay C, Öhlinger T, Kimberger O, Steinrigl A, Holzer B, Heger F, Indra A. Can We Protect Those We Care for in A Pandemic? – Prevalence of Neutralizing Antibodies against SARS-CoV-2 in Nursing Homes. Aging Dis. 2021 Jun 1;12(3):710-717. doi: 10.14336/AD.2021.0217. PMID: 34094636; PMCID: PMC8139192.
Eibensteiner F, Ritschl V, Nawaz FA, Fazel SS, Tsagkaris C, Kulnik ST, Crutzen R, Klager E, Völkl-Kernstock S, Schaden E, Kletecka-Pulker M, Willschke H, Atanasov AG. People’s Willingness to Vaccinate Against COVID-19 Despite Their Safety Concerns: Twitter Poll Analysis. J Med Internet Res. 2021 Apr 29;23(4):e28973. doi: 10.2196/28973. PMID: 33872185; PMCID: PMC8086789.
Kletečka-Pulker M, Völkl-Kernstock S, Fassl A, Klager E, Willschke H, Klomfar S, Wochele-Thoma T, Schaden E, Atanasov AG. Telehealth in Times of COVID-19: Spotlight on Austria. Healthcare (Basel). 2021 Mar 4;9(3):280. doi: 10.3390/healthcare9030280. PMID: 33806673; PMCID: PMC8001477.
Atanasov AG, Zotchev SB, Dirsch VM; International Natural Product Sciences Taskforce, Supuran CT. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov. 2021 Mar;20(3):200-216. doi: 10.1038/s41573-020-00114-z. Epub 2021 Jan 28. PMID: 33510482; PMCID: PMC7841765.
Yeung AWK, Atanasov AG, Sheridan H, Klager E, Eibensteiner F, Völkl-Kernsock S, Kletecka-Pulker M, Willschke H, Schaden E. Open Innovation in Medical and Pharmaceutical Research: A Literature Landscape Analysis. Front Pharmacol. 2021 Jan 14;11:587526. doi: 10.3389/fphar.2020.587526. PMID: 33519448; PMCID: PMC7840485.